ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

Wilson Disease: Its Medical And Clinical Implications, Diagnosis, Presentations, Course, Prognosis And Treatment

Updated on February 18, 2014

The Kayser-Fleischer Ring In Wilson Disease

Deposition of copper in the Descemet’s membrane layer of the cornea appears as a brownish yellow ring (Kayser- Fleischer) which merges to the limbus without a clear intervening zone
Deposition of copper in the Descemet’s membrane layer of the cornea appears as a brownish yellow ring (Kayser- Fleischer) which merges to the limbus without a clear intervening zone

Wilson's Disease

It is an inborn error of metabolism of copper inherited as autosomal recessive. Normally, copper which is absorbed from the gut is initially bound loosely to albumin, but very soon it binds firmly with reculoplasmin, which is a globulin produced in the liver. In Wilson’s disease, absorption of copper is normal or increased, but the ceruloplasmin in the plasma is absent or considerably reduced. Therefore, the serum copper remains loosely bound to albumin and gets deposited in various organs such as the liver, brain, cornea, kidneys, heart and muscles.

This leads to the damage of parenchymal tissues. The most prominent lesions are cirrhosis of the liver and damage to basal ganglia and renal tubules. Cirrhosis of the liver is more common in children. Clinical features of hepatic cirrhosis are manifest in different combincations. Complications like hepatic failure or hematemesis may follow. In the brain, copper is deposited mainly in the basal ganglia, cerebellum and cerebral cortex. This manifests as involuntary movements, extrapyramidal features, dementia, cerebellar disturbances and convulsions. Renal tubular damage results in generalized amino aciduria. Phosphaturia occurs resulting in osteomalacia and renal rickets.

Deposition of copper in the Descemet’s membrane layer of the cornea appears as a brownish yellow ring (Kayser- Fleischer) which merges to the limbus without a clear intervening zone. This has to be distinguished from corneal arcus in which a clear zone of cornea intervenes between the ring and the limbus. Kayser-Fleischer ring is best studied by slitlamp examination. Level of copper bound to ceruloplasmin is low whereas the unbound copper may be increased. Total serum copper is usually low.

Serum ceruloplasmin is low (normal is 18 to 65 mg/dl). Serum copper is below (80ug/dl) and urinary copper excretion is high (more than 100 ug in 24 hours). Content of copper in liver is high, i.e. more than 250 ug/g of dry weight (normal 20- 45 ug/g).

Diagnosis

Wilson’s disease should be suspected when ayoung person below 40 years presents with signs of hepatic dysfunction and neurological disease involving the extrapyramidal and cerebellar systems. Involvement of either system may predominate. Presence of Kayser- Fleischer ring is diagnostic. Studies of serum copper, ceruloplasmin and liver biopsy for hepatic copper serve to establish the diagnosis.

Course and prognosis: The disease steadily progresses to end fatally in 5- 14 years. Hepatic failure, hematemesis, or neurological deterioration account for the majority of deaths.

More Advanced Presentations Of Wilson Disease

Source

Treatment

Treatment aims at reduction of the absorption of copper from the gut and increasing the elimination of excess copper that is stored in tissues. Elimination is increased by chelating agents like penicillamine (dimethyl cysteine-Distamine, Cuprimine). The dose is 250 mg four times daily given orally before food and at bedtime. It leads to urinary loss of copper. Adverse side effects include nephrotoxicity, agranulocytosis, arthralgia, lupus-like syndrome, lymphadenopathy, rashes and thrombocytopenia. These are seen on starting the therapy. Side effects may necessitate temporary withdrawal of the drug. Many toxic effects are dose-related. Interruption of therapy leads to relapse of symptoms and therefore treatment has to be life-long.

Potassium sulphide given orally is effective in inhibiting absorption of copper from foods. Therapy can be monitored clinically and by biochemical tests for free copper, in the serum, urinary copper and hepatic transaminases. Tri-ethylene tetramine (Trientine) dihydrochloride is another chelating agent given in a dose of 400- 800 mg orally thrice daily before food. It is not yet freely available.

Screening of relatives: Since asymptomatic siblings show abnormality of copper transport, they have to be investigated with estimation of serum ceruloplasmin and hepatic copper. Early treatment helps in preventing the development of organ damage

© 2014 Funom Theophilus Makama

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://hubpages.com/privacy-policy#gdpr

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)